Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL823697 | 0.98 | MEN1 (0.50) | TSHRMAPK1MEN1KMT2AMAPT | |
| SCHEMBL16589825 | 0.98 | MEN1 (0.50) | TSHRMAPK1MEN1KMT2AMAPT | |
| SCHEMBL8898852 | 0.98 | MEN1 (0.50) | TSHRMAPK1MEN1KMT2AMAPT | |
| SCHEMBL18396496 | 0.98 | MEN1 (0.50) | TSHRMAPK1MEN1KMT2AMAPT | |
| SCHEMBL2530379 | 0.96 | MEN1 (0.54) | TSHRMAPK1MEN1KMT2AMAPT | |
| SCHEMBL1468539 | 0.96 | MEN1 (0.54) | TSHRMAPK1MEN1KMT2AMAPT | |
| SCHEMBL6150801 | 0.96 | MEN1 (0.54) | TSHRMAPK1MEN1KMT2AMAPT | |
| SCHEMBL826393 | 0.96 | MEN1 (0.54) | TSHRMAPK1MEN1KMT2AMAPT | |
| SCHEMBL11330924 | 0.93 | — | — | |
| SCHEMBL8898421 | 0.91 | LPAR3 (0.45) | TSHRMAPK1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5691434-A | ALKENYLOXYALKYL-SUBSTITUTED | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1997-11-25 | — | — | US | claimed |
| US-20260035494-A1 | METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS | GOODYEAR TIRE & RUBBER (US) | 2026-02-05 | — | — | US | disclosed |
| US-5691434-A | ALKENYLOXYALKYL-SUBSTITUTED | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1997-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035494-A1 | METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS | ITGA1, HSPA1A, SHC1 | TSHR 3645/4885MAPK1 1203/4885MEN1 4079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.